These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25684718)

  • 1. Fluoroscopic time: necessary but not sufficient.
    Balter S
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):400. PubMed ID: 25684718
    [No Abstract]   [Full Text] [Related]  

  • 2. Temporal trends of fluoroscopy time and contrast utilization in coronary chronic total occlusion revascularization: insights from a multicenter United States registry.
    Michael TT; Karmpaliotis D; Brilakis ES; Alomar M; Abdullah SM; Kirkland BL; Mishoe KL; Lembo N; Kalynych A; Carlson H; Banerjee S; Luna M; Lombardi W; Kandzari DE
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):393-9. PubMed ID: 24407867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in coronary interventions: an overview from the EAPCI registries.
    Barbato E; Dudek D; Baumbach A; Windecker S; Haude M
    EuroIntervention; 2017 May; 13(Z):Z8-Z10. PubMed ID: 28504221
    [No Abstract]   [Full Text] [Related]  

  • 4. What matters and what does not: variations in STEMI PCI techniques.
    Blankenship JC; Scott TD
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):727-8. PubMed ID: 24638947
    [No Abstract]   [Full Text] [Related]  

  • 5. Rebuttal: Location of femoral artery access and correlation with vascular complications.
    Pitta S
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):847. PubMed ID: 21953987
    [No Abstract]   [Full Text] [Related]  

  • 6. Transfemoral Approach for Coronary Angiography and Intervention: A Collaboration of International Cardiovascular Societies.
    Damluji AA; Nelson DW; Valgimigli M; Windecker S; Byrne RA; Cohen F; Patel T; Brilakis ES; Banerjee S; Mayol J; Cantor WJ; Alfonso CE; Rao SV; Moscucci M; Cohen MG
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2269-2279. PubMed ID: 29169496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedural variation in the performance of primary percutaneous coronary intervention for ST-elevation myocardial infarction: a SCAI-based survey study of US interventional cardiologists.
    Chiang A; Gada H; Kodali SK; Lee MS; Jeremias A; Pinto DS; Bangalore S; Yeh RW; Henry TD; Lopez-Cruz G; Mehran R; Kirtane AJ
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):721-6. PubMed ID: 24273213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of intraprocedural coronary computed tomographic angiography in percutaneous coronary intervention of chronic total occlusion.
    Kim BK; Sumitsuji S; Cho I; Hong MK; Kim JS; Chang HJ; Jang Y
    EuroIntervention; 2016 Mar; 11(12):1400. PubMed ID: 25947279
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions.
    Siudak Z; Grygier M; Wojakowski W; Malinowski KP; Witkowski A; Gąsior M; Dudek D; Bartuś S
    Catheter Cardiovasc Interv; 2020 Nov; 96(6):E568-E575. PubMed ID: 32686899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current practice of transradial approach for coronary procedures: A survey by the Italian Society of Interventional Cardiology (SICI-GISE) and the Italian Radial Club.
    Rigattieri S; Valsecchi O; Sciahbasi A; Tomassini F; Limbruno U; Marchese A; La Manna A; Mauro C; Varbella F; Berti S; Tarantino FF; Musumeci G
    Cardiovasc Revasc Med; 2017; 18(3):154-159. PubMed ID: 28119043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombectomy during primary PCI for STEMI-call of the thrombus.
    Topaz O
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1181-2. PubMed ID: 23225656
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Public Reporting on the Utilization of Coronary Angiography After Out-of-Hospital Cardiac Arrest.
    Nathan AS; Shah RM; Khatana SA; Dayoub E; Chatterjee P; Desai ND; Waldo SW; Yeh RW; Groeneveld PW; Giri J
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007564. PubMed ID: 30998398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate use criteria: lessons from Japan.
    Hung OY; Samady H; Anderson HV
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1010-3. PubMed ID: 25234673
    [No Abstract]   [Full Text] [Related]  

  • 14. Second opinion rights.
    King SB
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1079-80. PubMed ID: 25234684
    [No Abstract]   [Full Text] [Related]  

  • 15. Prasugrel: the real-life perspective.
    Serebruany V; Atar D
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):253-4. PubMed ID: 23674315
    [No Abstract]   [Full Text] [Related]  

  • 16. Can I be a star (or at least perform one)?
    Uretsky BF
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):797-8. PubMed ID: 19009626
    [No Abstract]   [Full Text] [Related]  

  • 17. EAPCI registries: a first step towards systematic monitoring of European interventional cardiology practice.
    Barbato E; Dudek D; Baumbach A; Windecker S; Haude M
    EuroIntervention; 2017 May; 13(Z):Z6-Z7. PubMed ID: 28504220
    [No Abstract]   [Full Text] [Related]  

  • 18. Upcoding of Clinical Information to Meet Appropriate Use Criteria for Percutaneous Coronary Intervention.
    Rajkumar CA; Suh WM; Francis DP
    Circ Cardiovasc Qual Outcomes; 2019 Mar; 12(3):e005025. PubMed ID: 30871374
    [No Abstract]   [Full Text] [Related]  

  • 19. Devising Productivity Benchmarks for IR: Findings from a National Survey of IR Practices.
    Cheung PY; Koran MEI; Oladini LK; Hofmann LV
    J Vasc Interv Radiol; 2020 Apr; 31(4):696-698.e13. PubMed ID: 32127317
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of CTO treated with minimum use of contrast media.
    Uehara Y; Shimizu M; Yoshimura M
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E884-7. PubMed ID: 23359535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.